Safety and efficacy of the new implantable phakic contact lens for the correction of myopia

Purpose: : To evaluation of the safety and efficacy of the implantable phakic contact lens (IPCL V1, Care group Sight Solutions, India) for correction of myopia and myopic astigmatism. Methods: This study including 28 eyes which underwent IPCL implantation for correction of myopia and myopic astigmatism. Visual acuity and manifest refraction, slit lamp bio microscopy, IOP and endothelial cell density was analysed postoperatively and compared with preoperative visits. Also Intraoperative and postoperative complications were evaluated. Results: The mean age of patient was 39.9 ±8.25 years old. the mean follow up was 5.1 months. Preoperative BCVA, sphere and astigmatism was 0.65 ± 0.18, -6.4 ±3.1 and -3.7±2.9 respectively. This parameters reach to 0.94±0.07, -0.2 ±0.3 and -0.88 ± 0.62 postoperatively. There are significant differences between this parameters at pre and post visits. (P< 0.05). At the preoperative visits, patients showed count fingers vision about 2 meters. The mean post operative UCVA reach to 0.71D ( range 0.4 to 1). No intraoperative complications were noted. The endothelial cell loss was 4.08%±3.18%. lens rotation was seen in one patient .One eye developed iris capture lens. No vision threatening complications were noted. Conclusion: The IPCL is a safe and effective treatment modality for correction of myopia and myopic astigmatism.